Cell kinetics and response to primary intra-arterial chemotherapy in patients with advanced oral cavity tumors

R. Molinari, A. Costa, S. Veneroni, F. Mattavelli, P. Salvatori, R. Silvestrini

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

The relationship was analyzed between cell kinetics, defined as 3H-thymidine labeling index (3H-TdR LI), and clinical responses for 35 previously untreated patients with locally advanced oral cavity squamous cell carcinomas. Patients were treated with three cycles of vincristine and bleomycin (VB) or of VB plus methotrexate (VBM), given by intra-arterial infusion followed by surgery. The objective clinical response rate was higher after VBM treatment than after VB, whereas overall clinical response rates were similar for patients with slowly or rapidly proliferating tumors. The probability of relapse-free survival at 4 yr and overall survival was significantly higher for patients with high 3H-TdR LI tumors given VBM than for those given VB. For patients with slowly proliferating tumors, there were no differences in relapse-free survival and overall survival between the two treatments. These data suggest that patients with rapidly proliferating tumors benefit from primary intensive chemotherapy treatment including methotrexate and that cell kinetics can be used to formulate rational clinical protocols for oral cavity cancers.

Original languageEnglish
Pages (from-to)32-36
Number of pages5
JournalJournal of Oral Pathology and Medicine
Volume20
Issue number1
DOIs
Publication statusPublished - 1991

Fingerprint

Mouth
Bleomycin
Vincristine
Methotrexate
Drug Therapy
Neoplasms
Survival
Recurrence
Intra Arterial Infusions
Mouth Neoplasms
Clinical Protocols
Thymidine
Squamous Cell Carcinoma
Therapeutics

ASJC Scopus subject areas

  • Cancer Research
  • Pathology and Forensic Medicine
  • Dentistry(all)

Cite this

Cell kinetics and response to primary intra-arterial chemotherapy in patients with advanced oral cavity tumors. / Molinari, R.; Costa, A.; Veneroni, S.; Mattavelli, F.; Salvatori, P.; Silvestrini, R.

In: Journal of Oral Pathology and Medicine, Vol. 20, No. 1, 1991, p. 32-36.

Research output: Contribution to journalArticle

Molinari, R. ; Costa, A. ; Veneroni, S. ; Mattavelli, F. ; Salvatori, P. ; Silvestrini, R. / Cell kinetics and response to primary intra-arterial chemotherapy in patients with advanced oral cavity tumors. In: Journal of Oral Pathology and Medicine. 1991 ; Vol. 20, No. 1. pp. 32-36.
@article{d72cbc6fdbf5480baa7b5f92146b21d9,
title = "Cell kinetics and response to primary intra-arterial chemotherapy in patients with advanced oral cavity tumors",
abstract = "The relationship was analyzed between cell kinetics, defined as 3H-thymidine labeling index (3H-TdR LI), and clinical responses for 35 previously untreated patients with locally advanced oral cavity squamous cell carcinomas. Patients were treated with three cycles of vincristine and bleomycin (VB) or of VB plus methotrexate (VBM), given by intra-arterial infusion followed by surgery. The objective clinical response rate was higher after VBM treatment than after VB, whereas overall clinical response rates were similar for patients with slowly or rapidly proliferating tumors. The probability of relapse-free survival at 4 yr and overall survival was significantly higher for patients with high 3H-TdR LI tumors given VBM than for those given VB. For patients with slowly proliferating tumors, there were no differences in relapse-free survival and overall survival between the two treatments. These data suggest that patients with rapidly proliferating tumors benefit from primary intensive chemotherapy treatment including methotrexate and that cell kinetics can be used to formulate rational clinical protocols for oral cavity cancers.",
author = "R. Molinari and A. Costa and S. Veneroni and F. Mattavelli and P. Salvatori and R. Silvestrini",
year = "1991",
doi = "10.1111/j.1600-0714.1991.tb00884.x",
language = "English",
volume = "20",
pages = "32--36",
journal = "Journal of Oral Pathology and Medicine",
issn = "0904-2512",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Cell kinetics and response to primary intra-arterial chemotherapy in patients with advanced oral cavity tumors

AU - Molinari, R.

AU - Costa, A.

AU - Veneroni, S.

AU - Mattavelli, F.

AU - Salvatori, P.

AU - Silvestrini, R.

PY - 1991

Y1 - 1991

N2 - The relationship was analyzed between cell kinetics, defined as 3H-thymidine labeling index (3H-TdR LI), and clinical responses for 35 previously untreated patients with locally advanced oral cavity squamous cell carcinomas. Patients were treated with three cycles of vincristine and bleomycin (VB) or of VB plus methotrexate (VBM), given by intra-arterial infusion followed by surgery. The objective clinical response rate was higher after VBM treatment than after VB, whereas overall clinical response rates were similar for patients with slowly or rapidly proliferating tumors. The probability of relapse-free survival at 4 yr and overall survival was significantly higher for patients with high 3H-TdR LI tumors given VBM than for those given VB. For patients with slowly proliferating tumors, there were no differences in relapse-free survival and overall survival between the two treatments. These data suggest that patients with rapidly proliferating tumors benefit from primary intensive chemotherapy treatment including methotrexate and that cell kinetics can be used to formulate rational clinical protocols for oral cavity cancers.

AB - The relationship was analyzed between cell kinetics, defined as 3H-thymidine labeling index (3H-TdR LI), and clinical responses for 35 previously untreated patients with locally advanced oral cavity squamous cell carcinomas. Patients were treated with three cycles of vincristine and bleomycin (VB) or of VB plus methotrexate (VBM), given by intra-arterial infusion followed by surgery. The objective clinical response rate was higher after VBM treatment than after VB, whereas overall clinical response rates were similar for patients with slowly or rapidly proliferating tumors. The probability of relapse-free survival at 4 yr and overall survival was significantly higher for patients with high 3H-TdR LI tumors given VBM than for those given VB. For patients with slowly proliferating tumors, there were no differences in relapse-free survival and overall survival between the two treatments. These data suggest that patients with rapidly proliferating tumors benefit from primary intensive chemotherapy treatment including methotrexate and that cell kinetics can be used to formulate rational clinical protocols for oral cavity cancers.

UR - http://www.scopus.com/inward/record.url?scp=0025957315&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025957315&partnerID=8YFLogxK

U2 - 10.1111/j.1600-0714.1991.tb00884.x

DO - 10.1111/j.1600-0714.1991.tb00884.x

M3 - Article

VL - 20

SP - 32

EP - 36

JO - Journal of Oral Pathology and Medicine

JF - Journal of Oral Pathology and Medicine

SN - 0904-2512

IS - 1

ER -